Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.
Press releases published on August 15, 2025
Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia
GlobeNewswire
·
August 15, 2025
Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 years Fibromyalgia is a chronic pain condition that affects more than 10 million adults in the U.S. who are mostly women Two Pivotal Phase 3 studies demonstrated Tonmya …
Princeton Brain, Spine and Sports Medicine Named a NJ Top Docs Practice for 2025 With 11 Reviewed and Approved Providers
EIN Presswire
·
August 15, 2025
NJ Top Docs has reviewed and approved Princeton Brain, Spine and Sports Medicine based on merit for 2025. PRINCETON, NJ, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- What began as a single-office practice has grown into a leading regional …
NJ Top Docs Honors Dr. Joseph A. Bordieri for 2025
EIN Presswire
·
August 15, 2025
Dr. Joseph A. Bordieri has been recognized by NJ Top Docs for his exceptional dedication to family medicine and his commitment to patient well-being. JAMESBURG, NJ, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- Dr. Joseph A. Bordieri, a board- …
Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation
GlobeNewswire
·
August 15, 2025
Game changer for stroke, Alzheimer’s, and beyond Shifting from peripheral to tissue-specific oxygenation monitoring BOSTON, MASSACHUSETTS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a pioneering clinical stage …
Recor Medical Responds to the American Heart Association (AHA) and American College of Cardiology’s (ACC) Updated Guidelines on Renal Denervation for the Treatment of Hypertension
GlobeNewswire
·
August 15, 2025
Palo Alto, CA, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), appreciate the American Heart Association (AHA) and American College of Cardiology (ACC) for …
Appeal launched to support people impacted by Newfoundland fires
GlobeNewswire
·
August 15, 2025
OTTAWA, Ontario, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the 2025 Newfoundland …
La Croix-Rouge met sur pied un fonds de secours en réponse aux feux de forêt à Terre-Neuve
GlobeNewswire
·
August 15, 2025
OTTAWA, Ontario, 15 août 2025 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne lance un appel aux dons au profit du Fonds de secours : Feux de forêt de 2025 à Terre-Neuve-et-Labrador afin de venir en aide aux personnes et aux communautés éprouvées par les …
HeartSciences Announces Conference Participation and Investor Webinar
GlobeNewswire
·
August 15, 2025
Southlake, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart …
AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 15, 2025
Continued progress across pipeline programs with focus on pancreatic cancer Mid-year report of Ampligen® (rintatolimod) in combination with AstraZeneca’s Imfinzi® (durvalumab) for the treatment of pancreatic cancer demonstrates promising signs of both no …
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
GlobeNewswire
·
August 15, 2025
First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile Initial development planned in obesity; BGE-102 demonstrated robust weight loss …
Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
GlobeNewswire
·
August 15, 2025
– Live video webcast on Thursday, August 21st at 2:20 PM ET THE WOODLANDS, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted …
Cingulate Provides Management Team Update
GlobeNewswire
·
August 15, 2025
Jennifer Callahan, Chief Financial Officer, appointed Interim CEO Board member, Jay Roberts appointed Executive Chairman KANSAS CITY, Kan., Aug. 15, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: CING) The Board of Directors of Cingulate Inc. (“Cingulate”) announced …
Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market
GlobeNewswire
·
August 15, 2025
SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial of HemaXellerate, the company’s innovative stem cell-derived therapy, which has already …
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 15, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …
Sienna Announces August Dividend
GlobeNewswire
·
August 15, 2025
MARKHAM, Ontario, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of August 2025, representing $0 …
Global Clinical Trial Supplies Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 15, 2025
Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Innovations in supply chain management and the rise of direct-to-patient models are transforming how life sciences companies execute global clinical trials. The global clinical trial supplies market, …
Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies
GlobeNewswire
·
August 15, 2025
Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue growth of 16%, supported by increased demand for drug …
Global Digital Pathology Market to Reach $13.7 Billion in 2029
GlobeNewswire
·
August 15, 2025
Boston, Aug. 15, 2025 (GLOBE NEWSWIRE) -- As global demand for precision diagnostics rises, digital pathology is reshaping how clinical labs, research institutions, and healthcare systems operate. From AI-assisted image analysis to remote pathology …
Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split
GlobeNewswire
·
August 15, 2025
FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced today that …
Stryker to host investor day
GlobeNewswire
·
August 15, 2025
Portage, Michigan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host an Investor Day on Thursday, November 13, 2025, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. A live audio webcast of the session, along with a replay, …